Apparatus for Measuring Glycation of Red Blood Cells and Glycated Hemoglobin Level Using Physical and Electrical Characteristics of Cells, and Related Methods

Orange

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application PCT/KR2021/018280, filed Dec 3, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 11,747,348	Apparatus for Measuring Glycation of Red Blood Cells and Glycated Hemoglobin Level Using Physical and Electrical Characteristics of Cells, and Related Methods Orange Biomed Co., Ltd. In force Term ends Dec 3, 2041 · High confidence	Orange Biomed Co., Ltd.	In force	Term ends Dec 3, 2041	Term ends Dec 3, 2041	High confidence
US 11,852,577	Apparatus for Measuring Properties of Particles in a Solution and Related Methods Orange Biomed Co., Ltd. In force Term ends Dec 3, 2041 · High confidence	Orange Biomed Co., Ltd.	In force	Term ends Dec 3, 2041	Term ends Dec 3, 2041	High confidence
US 12,013,404	Apparatus for Measuring Glycation of Red Blood Cells and Glycated Hemoglobin Level Using Physical and Electrical Characteristics of Cells, and Related Methods Orange Biomed Co., Ltd. In force Term ends Dec 3, 2041 · Medium confidence	Orange Biomed Co., Ltd.	In force	Term ends Dec 3, 2041	Term ends Dec 3, 2041	Medium confidence
US 12,019,082	Apparatus for Measuring Glycation of Red Blood Cells and Glycated Hemoglobin Level Using Physical and Electrical Characteristics of Cells, and Related Methods Orange Biomed Co., Ltd. In force Term ends Dec 3, 2041 · Medium confidence	Orange Biomed Co., Ltd.	In force	Term ends Dec 3, 2041	Term ends Dec 3, 2041	Medium confidence
US 12,025,548	Apparatus for Measuring Properties of Particles in a Solution and Related Methods Orange Biomed Co., Ltd. In force Term ends Dec 3, 2041 · Medium confidence	Orange Biomed Co., Ltd.	In force	Term ends Dec 3, 2041	Term ends Dec 3, 2041	Medium confidence
US 12,399,185	Apparatus for Measuring Glycation of Red Blood Cells and Glycated Hemoglobin Level Using Physical and Electrical Characteristics of Cells, and Related Methods Orange Biomed Co., Ltd. In force Term ends Dec 3, 2041 · Medium confidence	Orange Biomed Co., Ltd.	In force	Term ends Dec 3, 2041	Term ends Dec 3, 2041	Medium confidence
US 12,560,522	Apparatus for Measuring Properties of Particles in a Solution and Related Methods Orange Biomed Co., Ltd. In force Term ends Dec 3, 2041 · Medium confidence	Orange Biomed Co., Ltd.	In force	Term ends Dec 3, 2041	Term ends Dec 3, 2041	Medium confidence
Application 19/287,299	Apparatus for Measuring Glycation of Red Blood Cells and Glycated Hemoglobin Level Using Physical and Electrical Characteristics of Cells, and Related Methods Orange Biomed Co., Ltd. Pending Not granted	Orange Biomed Co., Ltd.	Pending	Not granted	not computed

8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

7 of these are in force and held by Orange.

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.